These results suggested that HTPB decreased migratory activities of lung cancer cells partly through inhibiting the activities of MMPs and RhoA protein and disrupting focal adhesion complex and F-actin cytoskeleton arrangement. The gene discussed is RHOA; the disease is lung cancer.